Australian (ASX) Stock Market Forum

SDV - SciDev Limited

$0.39

Q3 FY25 Quarterly Trading Update
SciDev delivers solid Q3 and progresses with strategic priorities against volatile market conditions.

Financial performance
Disciplined financial & capital management yields stable results.
• Revenue of $26.3m, up 10% Q2 FY25 ($23.8m).
• Gross profit margin of 29%.
• EBITDA of $2.1m, up 200% on Q2 FY25 ($0.7m).

Strategic delivery
Continued execution against strategy to support ongoing organic growth.
• Successfully increased market share in the US O&G market, growing our presence with target E&P operators in the Permian Basin & reducing overall customer concentration.
• Continued advancement of multiple key mining opportunities and secured a long-term trial with a global gold producer in Australia.
• Secured first PFAS contract US to treat investigation derived waste containing PFAS ‘forever chemicals’ at US Department of Defence installations.
• Domestic Water business active across multiple projects, including the construction of a $5.6m water treatment facility on a major NSW infrastructure project.
• Board changes support strategic growth.

Outlook
Growing market demand for SciDev technologies with timing impacts in Water and Mining.
• Healthy BD pipeline across all business units.
• Demand for proprietary chemistry remains strong, underpinning improved margins.
• Client driven delays in the Water & Mining businesses seeing timing of revenue from some projects shift into next FY
 


Write your reply...
Top